Financial Snapshot
Revenues
Revenues
Revenue YoY Change
Revenues
Expenses
Cost Of Revenues
Gross Profit
Gross Profit Margin
Gross Profit
Selling, General & Admin Expense
Research & Development
Depreciation, Depletion & Amortization
SGA Expense to Gross Profit Ratio
R&D To Gross Profit Ratio
DDA To Gross Profit Ratio
Operating Expenses Total
Operating Profits/Loss
Operational Expenses
Interest Expenses
Interest Expenses To Operating Income %
Other Expense/Income
Interest & Other Expense/Income
Income/Loss
Pretax Income
Income Tax
Net Profits/Loss
Pretax Income YoY Change
Income Tax Rate
Net Profits/Loss YoY Change
Basic EPS
Net Income To Revenue Ratio
Pretax & Net Income
Assets & Liabilities
Cash & Short-Term Investments
Cash & Equivalents
Cash To Operating Expenses Ratio
Inventory
Receivables
Total Short-Term Assets
Property, Plant And Equipment
Long-Term Investments
Total Long-Term Assets
Total Assets
Net Income To Total Assets Percentage
Accounts Payable
Short-Term Debt
Long Term Debt Due
Total Short-Term Liabilities
Long-Term Debt
Other Long-Term Liabilities
Total Long-Term Liabilities
Total Liabilities
Short-Term To Long-Term Debt Ratio
Short-Term Assets To Debt Ratio
Long-Term Debt To Net Income Ratio
Assets & Liabilities
Ownership
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares
Stock Issuance & Repurchase
Ownership Data
Return On Shareholders' Equity
Book Value
Free Cash Flow
Free Cash Flow YoY
Free Cash Flow Margin
Dividends
Dividends
Stock Price
About Cannabist Co Holdings Inc.
The Cannabist Company Holdings, Inc. engages in the production and sale of cannabis-based medicinal products. The company is headquartered in Chelmsford, Massachusetts and currently employs 2,191 full-time employees. The company went IPO on 2019-04-29. The Company’s principal business activity is the production and sale of cannabis as regulated by the regulatory bodies and authorities of the jurisdictions in which it operates. The firm operates approximately 124 facilities, including 93 dispensaries and 31 cultivation and manufacturing facilities, including those under development. The firm is a multi-state provider of cannabis in the United States and delivers products and services to both the medical and adult-use markets. Its retail brand, Cannabist, creates a national dispensary network that leverages proprietary technology platforms. The firm offers products spanning flower, edibles, oils and tablets, and manufactures brands including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber.
Industry: Agricultural Production-Crops Peers: Innoviva, Inc. AERIE PHARMACEUTICALS INC Amneal Pharmaceuticals, Inc. BIODELIVERY SCIENCES INTERNATIONAL INC COLLEGIUM PHARMACEUTICAL, INC DICE Therapeutics, Inc. NEKTAR THERAPEUTICS JOHNSON & JOHNSON SIGA TECHNOLOGIES INC
